Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip G Febbo

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Bioinformatics (Oxford, England)|July 29, 2006
Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profilesElena Edelman, Alessandro Porrello, Justin Guinney, et al.
Urology Practice|August 10, 2023
Utility of the Oncotype DX<sup>®</sup> Prostate Cancer Assay in Clinical Practice for Treatment Selection in Men Newly Diagnosed with Prostate Cancer: A Retrospective Chart Review AnalysisMarc A Dall'Era, Tara Maddala, Louise Polychronopoulos, et al.
Reviews in Urology|December 31, 2014
A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancerSteven E Canfield, Adam S Kibel, Michael J Kemeter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancerPhillip G Febbo, Aaron Thorner, Mark A Rubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Genomic strategy for targeting therapy in castration-resistant prostate cancerPrateek Mendiratta, Elahe Mostaghel, Justin Guinney, et al.
Plos One|October 11, 2017
Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)Michael S Leapman, Antonio C Westphalen, Niloufar Ameli, et al.
Cancer Research|March 3, 2006
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancerMichael Stanbrough, Glenn J Bubley, Kenneth Ross, et al.
BMC Genomics|December 20, 2007
Literature Lab: a method of automated literature interrogation to infer biology from microarray analysisPhillip G Febbo, Mike G Mulligan, David A Slonina, et al.
Molecular Cancer Therapeutics|October 15, 2008
A genomic approach to identify molecular pathways associated with chemotherapy resistanceRichard F Riedel, Alessandro Porrello, Emily Pontzer, et al.
Reviews in Urology|November 12, 2016
Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate ScoreDavid Albala, Michael J Kemeter, Phillip G Febbo, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Bioinformatics (Oxford, England)|July 29, 2006
Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profilesElena Edelman, Alessandro Porrello, Justin Guinney, et al.
Urology Practice|August 10, 2023
Utility of the Oncotype DX<sup>®</sup> Prostate Cancer Assay in Clinical Practice for Treatment Selection in Men Newly Diagnosed with Prostate Cancer: A Retrospective Chart Review AnalysisMarc A Dall'Era, Tara Maddala, Louise Polychronopoulos, et al.
Reviews in Urology|December 31, 2014
A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancerSteven E Canfield, Adam S Kibel, Michael J Kemeter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancerPhillip G Febbo, Aaron Thorner, Mark A Rubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Genomic strategy for targeting therapy in castration-resistant prostate cancerPrateek Mendiratta, Elahe Mostaghel, Justin Guinney, et al.
Plos One|October 11, 2017
Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)Michael S Leapman, Antonio C Westphalen, Niloufar Ameli, et al.
Cancer Research|March 3, 2006
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancerMichael Stanbrough, Glenn J Bubley, Kenneth Ross, et al.
BMC Genomics|December 20, 2007
Literature Lab: a method of automated literature interrogation to infer biology from microarray analysisPhillip G Febbo, Mike G Mulligan, David A Slonina, et al.
Molecular Cancer Therapeutics|October 15, 2008
A genomic approach to identify molecular pathways associated with chemotherapy resistanceRichard F Riedel, Alessandro Porrello, Emily Pontzer, et al.
Reviews in Urology|November 12, 2016
Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate ScoreDavid Albala, Michael J Kemeter, Phillip G Febbo, et al.
Pageof 8